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One sub-class of glycosidases of significant interest are the exo-N-acetyl-D-glucosaminidases which process Nacetylglucosamine residues from glycoconjugates. These enzymes are ubiquitous in all domains of life where, for 25 example, they play roles in peptidoglycan recycling, 11 bacterial virulence 12 and competition 13 , as well as diverse roles in eukaryotes.
14 As a result of the biological importance of these enzymes various different classes of inhibitor have been investigated. 30 One set of compounds which stand out as useful inhibitors of glycosidases are the hydroximolactones of which O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino Nphenylcarbamate (PUGNAc, Figure 1A ) is the best known member. 15, 16 This compound is a potent inhibitor of exo-N- 35 acetyl-D-glucosaminidases. 15, [17] [18] [19] [20] [21] The structural basis for the potency of hydroximolactones including PUGNAc lies, in part from these compounds possessing an sp 2 -hybridised carbon at C-1 which is thought to constrain these compounds to adopt a conformation resembling the geometry of the dissociative 40 SN 2 -like transition state of the reaction catalysed by glycosidases ( Figure 1B) . Another important feature is the oxime substituent, which mimics the aglycon of a natural substrate to harness additional binding energy.
15
Despite PUGNAc having the benefits of high potency and 45 membrane permeability, which make it suitable for cell-based studies, it lacks the selectivity, 17 which is critically important especially in eukaryotic systems containing multiplie exo-Nacetyl-D-glucosaminidases. This selectivity problem is also shared by other glycosidase inhibitors, including various aza-50 and iminosugars. 22, 23 In an effort to address the problems associated with selectivity, inhibitors have been designed where the compound scaffold is retained but elaborated with various chemical moieties. This method has met with success for various glycosidase inhibitors. To realise a divergent synthetic pathway we hypothesized that the colourigenic carbonate 1 would serve as a useful intermediate because formation of the carbamate can be 20 indirectly monitored by observation of the liberated 4-nitrophenolate anion. Thus, treatment of the readily prepared hydroximolactone 2, which is prepared using either the Nacetyl 16, 36 or Boc-protected 29 synthetic methodologies, with 4-nitrophenyl chloroformate gave the desired carbonate 1 in 25 good yield (Scheme 1). To test whether 1 would be suitably reactive with either substituted anilines or amines, we reacted 1 with aniline and, quite gratifyingly, obtained the phenyl carbamate 3 36 in good yield. To further improve the efficiency of the method we felt that the reaction to give the carbamate 3 30 from the carbonate 2 could work in a one-pot strategy. Thus treatment of 2 to give the presumed carbonate in situ followed by addition of aniline gave the carbamate 3 in good overall yield (Scheme 1).
Using this one-pot methodology we treated the 35 hydroximolactone 2 with a variety of aniline and amine derivatives that were comprised of a broad spectrum of materials with different size, shape and hydrophobic/hydrophilic propeties to yield a suite of acetylated analogues 4-33 (Scheme 1). Reaction times to 40 prepare the carbamates were variable, and were mainly dependent on the nucleophilicity of the amine utilised. Of interest is that the yields of the reactions were not generally affected by the nucleophilicity of the amine. Generally, the primary amines reacted completely with the in situ formed 45 carbonate 1, as judged by TLC, within one hour, however anilines required up to four days for complete reaction at room temperature. Removal of the O-acetyl protecting groups was achieved using ammonia in methanol to give the desired triols 34-63 in good overall yield.
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With these compounds in hand we evaluated them as potential inhibitors of three well characterised human enzymes, β-hexosaminidase B (HexB), NAGLU and OGA. NAGLU, see Supporting Information) we screened compounds 34-63 at two concentrations (100 nM and 10 µM) to gain a sense of the overall potency and selectivity of the compounds. We observed that these compounds are all inhibitors of these enzymes to varying extents (Figure 2 ).
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Analysis of the phenyl derivatives reveals 34-37, unsurprisingly, that this group of analogues generally shows similar potency to that of PUGNAc. Of note is the benzyl derivative 37, even though the molecule has increased rotation of the phenyl ring due to the methylene spacer, the potency 80 against the enzymes was not severely affected. The electronics of the phenyl ring seems to be important for inhibiton for all the enzymes tested with the electron donating methoxy group on 35 reducing the potency of the scaffold relative to PUGNAc, whilst electron deficient 36 showed similar potency 85 for HexB and OGA relative to PUGNAc. A potential reason for this observation lies in the binding interactions the phenyl ring makes in the +1 subsites of OGA and HexB. 35, 41 Generally the potency of the cyclic aliphatic derivatives 38-42, decreased with increasing ring size with the exception of 43-47 demonstrated that the glycine derivative 43 was 5 selective for HexB over OGA. Notably, the serine derivative 45 showed completely reversed selectivity as compared to PUGNAc and was selective for NAGLU over the the other two enzymes. This may be due to the polar serine group mimicking elements of the natural substrate of NAGLU which 10 is the polar molecule heparan sulfate. The additional hexyl chain of 47 proved to increase the potency of the parent scaffold 43 for HexB and particularly OGA, suggesting that these enzymes require some degree of hydrophobic character in the +1 subsite. However, this substituent was deleterious 15 for inhibition of NAGLU.
The aliphatic derivatives 48-58 were all less potent inhibitors than PUGNAc against the three Nacetylhexosaminidases. The N-2-chloroethyl derivative 58 did not show significant differences compared to the N-ethyl and 20 N-propyl analogues 49 and 50, which may be of interest in terms of enabling further functionalisation.
The N-isobutyl derivative 54 showed selectivity for HexB over OGA and the unsaturated derivatives 56 and 57 also showed similar selectivity when compared to 50. The compounds were not as potent as expected despite the extra electron density located in the aglycone portion of these 5 molecules. The alkyne 57 was selective for HexB over OGA and so sets the stage for this molecule potentially being used as a synthon in click chemistry based library approaches to generate triazole-based inhibitors of exo-N-acetyl-Dglucosaminidases. The N,N-disubstituted derivatives 59-63, 10 which lack one less hydrogen bond donor, were prepared to investigate the role that this H-bond may play in potency and selectivity. These compounds were inhibitors of all the enzymes tested, with 59, 60 and 63 showing selectivity for HexB over OGA. 15 With these activity assays in hand several inhibitors were carried forward to the next stage of evaluation, where K I values were obtained against the enzymes (Table 1 ). The trends observed in the rapid screen assay were consistent with the K I values obtained. Inhibitors lacking the phenyl ring were 20 significantly less potent than PUGNAc. The assay results were consistent with 35 being a worse inhibitor In conclusion we have developed a divergent synthetic route that enables the rapid synthesis of a series of PUGNAclike inhibitors bearing different carbamate groups. Using assays that allow for rapid screening we demonstrated that all the compounds prepared were inhibitors against the exo-N- 45 acetyl-D-glucosaminidases tested, HexB, NAGLU and OGA. Difference in potencies is consistent with differences in the active site architectures between these enzymes and suggests that modification of PUGNAc at this position warrants further investigation. Indeed these further investigations, using the 50 strategy outlined here may reveal even more selective inhibitors for these enzymes. Finally, we anticipate that these observations will, in combination with other structural variations, lead to highly selective tool compounds for these enzymes that could be used in cells and tissues. 55 
